Colin Harbour
Overview
Explore the profile of Colin Harbour including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
800
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang L, Sun J, Wang C, Woodman K, Li L, Wu L, et al.
Cell Transplant
. 2017 Sep;
9(3):329-336.
PMID: 28880657
In order to achieve optimal BALSS function, preparation of porcine hepatocytes with high yield, viability, and P450 activity is known to be important. To date hepatocyte yields have varied from...
2.
Harmer C, Wynn M, Pinto R, Cordwell S, Rose B, Harbour C, et al.
PLoS One
. 2015 Aug;
10(8):e0134229.
PMID: 26252386
Some Pseudomonas aeruginosa strains including Australian Epidemic Strain-1 (AES-1 or AUS-01) cause persistent chronic infection in cystic fibrosis (CF) patients, with greater morbidity and mortality. Factors conferring persistence are largely...
3.
Harmer C, Alnassafi K, Hu H, Elkins M, Bye P, Rose B, et al.
Microbiology (Reading)
. 2013 Sep;
159(Pt 11):2354-2363.
PMID: 24014664
Chronic Pseudomonas aeruginosa infection is the leading cause of morbidity and mortality in cystic fibrosis (CF) patients. P. aeruginosa isolates undergo significant transcriptomic and proteomic modulation as they adapt to...
4.
Hare N, Solis N, Harmer C, Marzook N, Rose B, Harbour C, et al.
BMC Microbiol
. 2012 Jan;
12:16.
PMID: 22264352
Background: Pseudomonas aeruginosa is an opportunistic pathogen that is the major cause of morbidity and mortality in patients with cystic fibrosis (CF). While most CF patients are thought to acquire...
5.
Hare N, Soe C, Rose B, Harbour C, Codd R, Manos J, et al.
J Proteome Res
. 2011 Nov;
11(2):776-95.
PMID: 22054071
Pseudomonas aeruginosa is an opportunistic pathogen that is the major cause of morbidity and mortality in patients with cystic fibrosis (CF). While most CF patients are thought to acquire P....
6.
Tingpej P, Elkins M, Rose B, Hu H, Moriarty C, Manos J, et al.
Respirology
. 2010 Jun;
15(6):923-9.
PMID: 20573059
Background And Objective: Earlier reports suggested that Pseudomonas aeruginosa frequent epidemic clones circulating in cystic fibrosis (CF) centres had increased virulence. However, recent data show no consistent associations with virulence,...
7.
Fung C, Naughton S, Turnbull L, Tingpej P, Rose B, Arthur J, et al.
J Med Microbiol
. 2010 Jun;
59(Pt 9):1089-1100.
PMID: 20522626
Pseudomonas aeruginosa airway infection is the leading cause of morbidity and mortality in cystic fibrosis (CF) patients. Various in vitro models have been developed to study P. aeruginosa pathobiology in...
8.
Kidd T, Marks G, Bye P, Wainwright C, Robinson P, Rose B, et al.
Respirology
. 2009 Sep;
14(7):1051-5.
PMID: 19740265
Background And Objective: Human research ethics committees provide essential review of research projects to ensure the ethical conduct of human research. Several recent reports have highlighted a complex process for...
9.
Kidd T, Ramsay K, Hu H, Bye P, Elkins M, Grimwood K, et al.
J Clin Microbiol
. 2009 Mar;
47(5):1503-9.
PMID: 19261796
Pseudomonas aeruginosa is an important cause of pulmonary infection in cystic fibrosis (CF). Its correct identification ensures effective patient management and infection control strategies. However, little is known about how...
10.
Manos J, Arthur J, Rose B, Bell S, Tingpej P, Hu H, et al.
FEMS Microbiol Lett
. 2009 Feb;
292(1):107-14.
PMID: 19222585
Epidemic Pseudomonas aeruginosa have been identified in cystic fibrosis (CF) patients worldwide. The Australian Epidemic Strain-2 (AES-2) infects up to 40% of patients in three eastern Australian CF clinics. To...